Larger trials that address these questions while prioritizing FDA-accepted efficacy end points 40 will ultimately inform the potential of GLP-1RAs as an emergent class of AUD therapies
Withdrawal, however, predictably results in weight regain, primarily as fat mass, highlighting the importance of continued therapy or supportive lifestyle strategies
By contrast, real-world persistence drops off a cliff fairly early on
Not suitable for pregnant/breastfeeding women, or individuals with kidney, liver, or active infection conditions
Cell Plasticity in Liver Regeneration
One of the sirtuin family of deacetylases, SIRT3, has been shown to be the major mitochondrial deacetylase controlling the level of SDHA acetylation